位置:首页 > 蛋白库 > THAP4_HUMAN
THAP4_HUMAN
ID   THAP4_HUMAN             Reviewed;         577 AA.
AC   Q8WY91; Q53NU7; Q6GRN0; Q6IPJ3; Q9NW26; Q9Y325;
DT   11-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-APR-2003, sequence version 2.
DT   03-AUG-2022, entry version 163.
DE   RecName: Full=Peroxynitrite isomerase THAP4 {ECO:0000305|PubMed:30524950};
DE            EC=5.99.-.- {ECO:0000269|PubMed:30524950};
DE   AltName: Full=Ferric Homo sapiens nitrobindin {ECO:0000303|PubMed:32295384};
DE            Short=Hs-Nb(III) {ECO:0000303|PubMed:32295384};
DE   AltName: Full=THAP domain-containing protein 4 {ECO:0000312|HGNC:HGNC:23187};
GN   Name=THAP4 {ECO:0000312|HGNC:HGNC:23187}; ORFNames=CGI-36, PP238;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-121.
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-121.
RC   TISSUE=Brain, Eye, Melanoma, and Ovarian carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 221-577 (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-163, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND DOMAIN.
RX   PubMed=30524950; DOI=10.1002/2211-5463.12534;
RA   De Simone G., di Masi A., Polticelli F., Ascenzi P.;
RT   "Human nitrobindin: the first example of an all-beta-barrel ferric heme-
RT   protein that catalyzes peroxynitrite detoxification.";
RL   FEBS Open Bio 8:2002-2010(2018).
RN   [9]
RP   FUNCTION, COFACTOR, AND NO-BINDING.
RX   PubMed=32295384; DOI=10.1089/ars.2019.7874;
RA   De Simone G., di Masi A., Vita G.M., Polticelli F., Pesce A., Nardini M.,
RA   Bolognesi M., Ciaccio C., Coletta M., Turilli E.S., Fasano M.,
RA   Tognaccini L., Smulevich G., Abbruzzetti S., Viappiani C., Bruno S.,
RA   Ascenzi P.;
RT   "Mycobacterial and Human Nitrobindins: Structure and Function.";
RL   Antioxid. Redox Signal. 33:229-246(2020).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 415-577 IN COMPLEX WITH HEME,
RP   COFACTOR, SUBUNIT, AND DOMAIN.
RX   PubMed=21387410; DOI=10.1002/prot.22944;
RA   Bianchetti C.M., Bingman C.A., Phillips G.N. Jr.;
RT   "Structure of the C-terminal heme-binding domain of THAP domain containing
RT   protein 4 from Homo sapiens.";
RL   Proteins 79:1337-1341(2011).
CC   -!- FUNCTION: Heme-binding protein able to scavenge peroxynitrite and to
CC       protect free L-tyrosine against peroxynitrite-mediated nitration, by
CC       acting as a peroxynitrite isomerase that converts peroxynitrite to
CC       nitrate. Therefore, this protein likely plays a role in peroxynitrite
CC       sensing and in the detoxification of reactive nitrogen and oxygen
CC       species (RNS and ROS, respectively). Is able to bind nitric oxide (NO)
CC       in vitro, but may act as a sensor of peroxynitrite levels in vivo,
CC       possibly modulating the transcriptional activity residing in the N-
CC       terminal region. {ECO:0000269|PubMed:30524950,
CC       ECO:0000269|PubMed:32295384}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=peroxynitrite = nitrate; Xref=Rhea:RHEA:63116,
CC         ChEBI:CHEBI:17632, ChEBI:CHEBI:25941;
CC         Evidence={ECO:0000269|PubMed:30524950};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63117;
CC         Evidence={ECO:0000305|PubMed:30524950};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000269|PubMed:21387410, ECO:0000269|PubMed:32295384};
CC       Note=Binds 1 heme b group per subunit, that coordinates a highly
CC       solvent-exposed Fe(III) atom. {ECO:0000269|PubMed:32295384};
CC   -!- PATHWAY: Nitrogen metabolism. {ECO:0000305|PubMed:30524950}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:21387410}.
CC   -!- INTERACTION:
CC       Q8WY91; Q6RW13-2: AGTRAP; NbExp=3; IntAct=EBI-726691, EBI-11522760;
CC       Q8WY91; Q9NVV5-2: AIG1; NbExp=3; IntAct=EBI-726691, EBI-11957045;
CC       Q8WY91; P17707: AMD1; NbExp=3; IntAct=EBI-726691, EBI-6872827;
CC       Q8WY91; Q86W74-2: ANKRD46; NbExp=3; IntAct=EBI-726691, EBI-12109402;
CC       Q8WY91; Q8WZ55: BSND; NbExp=3; IntAct=EBI-726691, EBI-7996695;
CC       Q8WY91; Q06432: CACNG1; NbExp=3; IntAct=EBI-726691, EBI-9686780;
CC       Q8WY91; P60033: CD81; NbExp=3; IntAct=EBI-726691, EBI-712921;
CC       Q8WY91; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-726691, EBI-11522780;
CC       Q8WY91; Q96FZ5: CMTM7; NbExp=3; IntAct=EBI-726691, EBI-2807956;
CC       Q8WY91; P29400-2: COL4A5; NbExp=3; IntAct=EBI-726691, EBI-12211159;
CC       Q8WY91; Q96FN4: CPNE2; NbExp=5; IntAct=EBI-726691, EBI-7097057;
CC       Q8WY91; P78329: CYP4F2; NbExp=3; IntAct=EBI-726691, EBI-1752413;
CC       Q8WY91; Q6ZPD8: DGAT2L6; NbExp=3; IntAct=EBI-726691, EBI-12831978;
CC       Q8WY91; Q9Y680: FKBP7; NbExp=3; IntAct=EBI-726691, EBI-3918971;
CC       Q8WY91; Q8WWP7: GIMAP1; NbExp=3; IntAct=EBI-726691, EBI-11991950;
CC       Q8WY91; O60883: GPR37L1; NbExp=3; IntAct=EBI-726691, EBI-2927498;
CC       Q8WY91; P24593: IGFBP5; NbExp=3; IntAct=EBI-726691, EBI-720480;
CC       Q8WY91; O43561-2: LAT; NbExp=3; IntAct=EBI-726691, EBI-8070286;
CC       Q8WY91; Q9UBY5: LPAR3; NbExp=3; IntAct=EBI-726691, EBI-12033434;
CC       Q8WY91; Q969L2: MAL2; NbExp=5; IntAct=EBI-726691, EBI-944295;
CC       Q8WY91; P11836: MS4A1; NbExp=3; IntAct=EBI-726691, EBI-2808234;
CC       Q8WY91; Q9ULP0-2: NDRG4; NbExp=3; IntAct=EBI-726691, EBI-11978907;
CC       Q8WY91; Q04941: PLP2; NbExp=3; IntAct=EBI-726691, EBI-608347;
CC       Q8WY91; Q59EV6: PPGB; NbExp=3; IntAct=EBI-726691, EBI-14210385;
CC       Q8WY91; Q96LZ7: RMDN2; NbExp=3; IntAct=EBI-726691, EBI-2806908;
CC       Q8WY91; Q5QGT7: RTP2; NbExp=3; IntAct=EBI-726691, EBI-10244780;
CC       Q8WY91; O15126: SCAMP1; NbExp=3; IntAct=EBI-726691, EBI-954338;
CC       Q8WY91; Q8IWU4: SLC30A8; NbExp=3; IntAct=EBI-726691, EBI-10262251;
CC       Q8WY91; P08247: SYP; NbExp=3; IntAct=EBI-726691, EBI-9071725;
CC       Q8WY91; Q8WY91: THAP4; NbExp=3; IntAct=EBI-726691, EBI-726691;
CC       Q8WY91; Q6UX40: TMEM107; NbExp=3; IntAct=EBI-726691, EBI-12845616;
CC       Q8WY91; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-726691, EBI-2852148;
CC       Q8WY91; Q8N2M4: TMEM86A; NbExp=3; IntAct=EBI-726691, EBI-12015604;
CC       Q8WY91; Q8N661: TMEM86B; NbExp=3; IntAct=EBI-726691, EBI-2548832;
CC       Q8WY91; Q9UBN6: TNFRSF10D; NbExp=3; IntAct=EBI-726691, EBI-1044859;
CC       Q8WY91; P55327-2: TPD52; NbExp=3; IntAct=EBI-726691, EBI-12124194;
CC       Q8WY91; P49638: TTPA; NbExp=3; IntAct=EBI-726691, EBI-10210710;
CC       Q8WY91; Q96EC8: YIPF6; NbExp=3; IntAct=EBI-726691, EBI-751210;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Localizes mainly in the
CC       cytoplasm and partially in the nucleus. {ECO:0000269|PubMed:32295384}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WY91-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WY91-2; Sequence=VSP_020078, VSP_020079;
CC   -!- DOMAIN: The C-terminal nitrobindin region coordinates a heme and bears
CC       the isomerase activity. The N-terminal zinc finger domain likely binds
CC       DNA and may be involved in transcriptional regulation.
CC       {ECO:0000269|PubMed:21387410, ECO:0000269|PubMed:30524950}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the nitrobindin
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH00247.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH09439.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA91560.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF132970; AAD27745.1; -; mRNA.
DR   EMBL; AF258556; AAG23759.1; -; mRNA.
DR   EMBL; AC133528; AAY14918.1; -; Genomic_DNA.
DR   EMBL; BC000247; AAH00247.1; ALT_INIT; mRNA.
DR   EMBL; BC009439; AAH09439.1; ALT_INIT; mRNA.
DR   EMBL; BC069235; AAH69235.1; -; mRNA.
DR   EMBL; BC071896; AAH71896.1; -; mRNA.
DR   EMBL; BC094822; AAH94822.1; -; mRNA.
DR   EMBL; AK001216; BAA91560.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2551.1; -. [Q8WY91-1]
DR   CCDS; CCDS54440.1; -. [Q8WY91-2]
DR   RefSeq; NP_001157828.1; NM_001164356.1. [Q8WY91-2]
DR   RefSeq; NP_057047.4; NM_015963.5. [Q8WY91-1]
DR   PDB; 3IA8; X-ray; 1.79 A; A/B=415-577.
DR   PDBsum; 3IA8; -.
DR   AlphaFoldDB; Q8WY91; -.
DR   SMR; Q8WY91; -.
DR   BioGRID; 119269; 73.
DR   IntAct; Q8WY91; 56.
DR   MINT; Q8WY91; -.
DR   STRING; 9606.ENSP00000385006; -.
DR   iPTMnet; Q8WY91; -.
DR   PhosphoSitePlus; Q8WY91; -.
DR   BioMuta; THAP4; -.
DR   DMDM; 29839589; -.
DR   EPD; Q8WY91; -.
DR   jPOST; Q8WY91; -.
DR   MassIVE; Q8WY91; -.
DR   MaxQB; Q8WY91; -.
DR   PaxDb; Q8WY91; -.
DR   PeptideAtlas; Q8WY91; -.
DR   PRIDE; Q8WY91; -.
DR   ProteomicsDB; 75134; -. [Q8WY91-1]
DR   ProteomicsDB; 75135; -. [Q8WY91-2]
DR   Antibodypedia; 34568; 77 antibodies from 23 providers.
DR   DNASU; 51078; -.
DR   Ensembl; ENST00000402136.5; ENSP00000385931.1; ENSG00000176946.13. [Q8WY91-2]
DR   Ensembl; ENST00000407315.6; ENSP00000385006.1; ENSG00000176946.13. [Q8WY91-1]
DR   GeneID; 51078; -.
DR   KEGG; hsa:51078; -.
DR   MANE-Select; ENST00000407315.6; ENSP00000385006.1; NM_015963.6; NP_057047.4.
DR   UCSC; uc002wbs.3; human. [Q8WY91-1]
DR   CTD; 51078; -.
DR   GeneCards; THAP4; -.
DR   HGNC; HGNC:23187; THAP4.
DR   HPA; ENSG00000176946; Low tissue specificity.
DR   MIM; 612533; gene.
DR   neXtProt; NX_Q8WY91; -.
DR   OpenTargets; ENSG00000176946; -.
DR   PharmGKB; PA134864723; -.
DR   VEuPathDB; HostDB:ENSG00000176946; -.
DR   eggNOG; KOG3371; Eukaryota.
DR   GeneTree; ENSGT00940000158447; -.
DR   HOGENOM; CLU_085483_1_1_1; -.
DR   InParanoid; Q8WY91; -.
DR   OrthoDB; 1382095at2759; -.
DR   PhylomeDB; Q8WY91; -.
DR   TreeFam; TF315956; -.
DR   PathwayCommons; Q8WY91; -.
DR   SignaLink; Q8WY91; -.
DR   BioGRID-ORCS; 51078; 23 hits in 1098 CRISPR screens.
DR   ChiTaRS; THAP4; human.
DR   EvolutionaryTrace; Q8WY91; -.
DR   GeneWiki; THAP4; -.
DR   GenomeRNAi; 51078; -.
DR   Pharos; Q8WY91; Tbio.
DR   PRO; PR:Q8WY91; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q8WY91; protein.
DR   Bgee; ENSG00000176946; Expressed in apex of heart and 201 other tissues.
DR   ExpressionAtlas; Q8WY91; baseline and differential.
DR   Genevisible; Q8WY91; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0020037; F:heme binding; IMP:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070026; F:nitric oxide binding; IDA:UniProtKB.
DR   GO; GO:0062213; F:peroxynitrite isomerase activity; IDA:UniProtKB.
DR   GO; GO:0042126; P:nitrate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006570; P:tyrosine metabolic process; IDA:UniProtKB.
DR   CDD; cd07828; lipocalin_heme-bd-THAP4-like; 1.
DR   Gene3D; 2.40.128.20; -; 1.
DR   Gene3D; 6.20.210.20; -; 1.
DR   InterPro; IPR012674; Calycin.
DR   InterPro; IPR045165; Nitrobindin.
DR   InterPro; IPR014878; THAP4-like_heme-bd.
DR   InterPro; IPR006612; THAP_Znf.
DR   InterPro; IPR038441; THAP_Znf_sf.
DR   PANTHER; PTHR15854; PTHR15854; 1.
DR   Pfam; PF05485; THAP; 1.
DR   Pfam; PF08768; THAP4_heme-bd; 1.
DR   SMART; SM00692; DM3; 1.
DR   SMART; SM00980; THAP; 1.
DR   SUPFAM; SSF50814; SSF50814; 1.
DR   PROSITE; PS50950; ZF_THAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; DNA-binding; Heme; Iron;
KW   Isomerase; Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..577
FT                   /note="Peroxynitrite isomerase THAP4"
FT                   /id="PRO_0000068646"
FT   ZN_FING         1..85
FT                   /note="THAP-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00309"
FT   REGION          84..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          240..324
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          415..577
FT                   /note="Nitrobindin"
FT                   /evidence="ECO:0000269|PubMed:21387410,
FT                   ECO:0000269|PubMed:30524950"
FT   MOTIF           235..238
FT                   /note="HCFC1-binding motif (HBM)"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WTV1"
FT   COMPBIAS        90..109
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        113..137
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        157..171
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        197..211
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        241..266
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..296
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         444
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:21387410,
FT                   ECO:0007744|PDB:3IA8"
FT   BINDING         567
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000269|PubMed:21387410,
FT                   ECO:0007744|PDB:3IA8"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..412
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10810093"
FT                   /id="VSP_020078"
FT   VAR_SEQ         413
FT                   /note="R -> M (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10810093"
FT                   /id="VSP_020079"
FT   VARIANT         121
FT                   /note="S -> G (in dbSNP:rs7424328)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:15498874"
FT                   /id="VAR_027161"
FT   CONFLICT        261
FT                   /note="L -> P (in Ref. 5; BAA91560)"
FT                   /evidence="ECO:0000305"
FT   HELIX           420..428
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          430..436
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          438..442
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          445..457
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          459..471
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   TURN            473..475
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          478..488
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          494..501
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   TURN            502..504
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          505..514
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          517..527
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          536..545
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          551..559
FT                   /evidence="ECO:0007829|PDB:3IA8"
FT   STRAND          562..576
FT                   /evidence="ECO:0007829|PDB:3IA8"
SQ   SEQUENCE   577 AA;  62890 MW;  40660A5ACDD0A7C3 CRC64;
     MVICCAAVNC SNRQGKGEKR AVSFHRFPLK DSKRLIQWLK AVQRDNWTPT KYSFLCSEHF
     TKDSFSKRLE DQHRLLKPTA VPSIFHLTEK KRGAGGHGRT RRKDASKATG GVRGHSSAAT
     SRGAAGWSPS SSGNPMAKPE SRRLKQAALQ GEATPRAAQE AASQEQAQQA LERTPGDGLA
     TMVAGSQGKA EASATDAGDE SATSSIEGGV TDKSGISMDD FTPPGSGACK FIGSLHSYSF
     SSKHTRERPS VPREPIDRKR LKKDVEPSCS GSSLGPDKGL AQSPPSSSLT ATPQKPSQSP
     SAPPADVTPK PATEAVQSEH SDASPMSINE VILSASGACK LIDSLHSYCF SSRQNKSQVC
     CLREQVEKKN GELKSLRQRV SRSDSQVRKL QEKLDELRRV SVPYPSSLLS PSREPPKMNP
     VVEPLSWMLG TWLSDPPGAG TYPTLQPFQY LEEVHISHVG QPMLNFSFNS FHPDTRKPMH
     RECGFIRLKP DTNKVAFVSA QNTGVVEVEE GEVNGQELCI ASHSIARISF AKEPHVEQIT
     RKFRLNSEGK LEQTVSMATT TQPMTQHLHV TYKKVTP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024